What's breaking now, across thousands of outlets.
The clearance of Genglycos for a rare glycogen storage disease gives Ultragenyx a sellable voucher and momentum ahead of an eagerly anticipated study readout.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Die Börse feiert den Studienerfolg von Moderna und Merck. Ein personalisierter Krebsimpfstoff rückt näher und könnte ein Gamechanger für die Krebsmedizin werden.
PrEP is an HIV prevention intervention for people who do not have HIV but may be at risk of acquiring the virus. It involves the use of medicines to reduce the risk of HIV infection.
Musician, who revealed first Hodgkin's lymphoma diagnosis in 2013, says cancer's return won't slow him down
There is no cure for dementia, and as the condition progresses, the patient may not be able to recognize loved ones.
Dehydration can affect much more than your thirst. It also can place extra stress on your heart and cardiovascular system, explains Dr.
